EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate Aug. 11, 2017 No Comments
FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV Aug. 11, 2017 No Comments
Mologen announces results from extension phase of TEACH study of lefitolimod in HIV Aug. 10, 2017 No Comments
Mylan receives PEPFAR tentative approval for TLD fixed-dose combination regimen Aug. 8, 2017 No Comments
Janssen reports results of APPROACH study of Ad26.Mos.HIV HIV-1 vaccine regimens Aug. 8, 2017 No Comments
The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies Aug. 7, 2017 No Comments
Dolutegravir superior in combination with NRTIs for treating HIV-1 infection Aug. 4, 2017 No Comments
RSS